73 related articles for article (PubMed ID: 9918789)
21. Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding.
Kuczius T; Buschmann A; Zhang W; Karch H; Becker K; Peters G; Groschup MH
Biol Chem; 2004 Aug; 385(8):739-47. PubMed ID: 15449710
[TBL] [Abstract][Full Text] [Related]
22. Octapeptide repeat region of prion protein (PrP) is required at an early stage for production of abnormal prion protein in PrP-deficient neuronal cell line.
Sakudo A; Wu G; Onodera T; Ikuta K
Biochem Biophys Res Commun; 2008 Jan; 365(1):164-9. PubMed ID: 17981146
[TBL] [Abstract][Full Text] [Related]
23. Use of a new immunoassay to measure PrP Sc levels in scrapie-infected sheep brains reveals PrP genotype-specific differences.
McCutcheon S; Hunter N; Houston F
J Immunol Methods; 2005 Mar; 298(1-2):119-28. PubMed ID: 15847802
[TBL] [Abstract][Full Text] [Related]
24. Detection, quantification, and glycotyping of prion protein in specifically activated enzyme-linked immunosorbent assay plates.
Triantaphyllidou IE; Sklaviadis T; Vynios DH
Anal Biochem; 2006 Dec; 359(2):176-82. PubMed ID: 17092479
[TBL] [Abstract][Full Text] [Related]
25. The metabolism of glycosaminoglycans is impaired in prion diseases.
Mayer-Sonnenfeld T; Zeigler M; Halimi M; Dayan Y; Herzog C; Lasmezas CI; Gabizon R
Neurobiol Dis; 2005 Dec; 20(3):738-43. PubMed ID: 15951190
[TBL] [Abstract][Full Text] [Related]
26. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
[TBL] [Abstract][Full Text] [Related]
27. Prion proteins: a biological role beyond prion diseases.
Hu W; Rosenberg RN; Stüve O
Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
[TBL] [Abstract][Full Text] [Related]
28. Detection of prion particles in samples of BSE and scrapie by fluorescence correlation spectroscopy without proteinase K digestion.
Birkmann E; Schäfer O; Weinmann N; Dumpitak C; Beekes M; Jackman R; Thorne L; Riesner D
Biol Chem; 2006 Jan; 387(1):95-102. PubMed ID: 16497169
[TBL] [Abstract][Full Text] [Related]
29. Acidic pH and detergents enhance in vitro conversion of human brain PrPC to a PrPSc-like form.
Zou WQ; Cashman NR
J Biol Chem; 2002 Nov; 277(46):43942-7. PubMed ID: 12161431
[TBL] [Abstract][Full Text] [Related]
30. Binding of N- and C-terminal anti-prion protein antibodies generates distinct phenotypes of cellular prion proteins (PrPC) obtained from human, sheep, cattle and mouse.
Kuczius T; Grassi J; Karch H; Groschup MH
FEBS J; 2007 Mar; 274(6):1492-502. PubMed ID: 17302739
[TBL] [Abstract][Full Text] [Related]
31. Regional and phenotype heterogeneity of cellular prion proteins in the human brain.
Kuczius T; Koch R; Keyvani K; Karch H; Grassi J; Groschup MH
Eur J Neurosci; 2007 May; 25(9):2649-55. PubMed ID: 17466020
[TBL] [Abstract][Full Text] [Related]
32. Absolute and relative quantification of sheep brain prion protein (PrP) allelic variants by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry.
Morel N; Andréoletti O; Grassi J; Clément G
Rapid Commun Mass Spectrom; 2007; 21(24):4093-100. PubMed ID: 18008391
[TBL] [Abstract][Full Text] [Related]
33. Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.
Chiesa R; Pestronk A; Schmidt RE; Tourtellotte WG; Ghetti B; Piccardo P; Harris DA
Neurobiol Dis; 2001 Apr; 8(2):279-88. PubMed ID: 11300723
[TBL] [Abstract][Full Text] [Related]
34. Ovine plasma prion protein levels show genotypic variation detected by C-terminal epitopes not exposed in cell-surface PrPC.
Thackray AM; Fitzmaurice TJ; Hopkins L; Bujdoso R
Biochem J; 2006 Dec; 400(2):349-58. PubMed ID: 16881870
[TBL] [Abstract][Full Text] [Related]
35. Proteinase K and the structure of PrPSc: The good, the bad and the ugly.
Silva CJ; Vázquez-Fernández E; Onisko B; Requena JR
Virus Res; 2015 Sep; 207():120-6. PubMed ID: 25816779
[TBL] [Abstract][Full Text] [Related]
36. The retention of prion protein in the endoplasmic reticulum prevents N2A cells from proteasome inhibition-induced cytotoxicity.
Fang S; Wang R; Liu H; Zhuang W; Wang Z; Zhang J; Pei L; Liu Y; Su Y
Biochem Biophys Res Commun; 2017 Sep; 491(2):500-507. PubMed ID: 28669732
[TBL] [Abstract][Full Text] [Related]
37. Probing structural differences between PrP(C) and PrP(Sc) by surface nitration and acetylation: evidence of conformational change in the C-terminus.
Gong B; Ramos A; Vázquez-Fernández E; Silva CJ; Alonso J; Liu Z; Requena JR
Biochemistry; 2011 Jun; 50(22):4963-72. PubMed ID: 21526750
[TBL] [Abstract][Full Text] [Related]
38. Microdeletions within the hydrophobic core region of cellular prion protein alter its topology and metabolism.
Lutz J; Brabeck C; Niemann HH; Kloz U; Korth C; Lingappa VR; Bürkle A
Biochem Biophys Res Commun; 2010 Mar; 393(3):439-44. PubMed ID: 20138835
[TBL] [Abstract][Full Text] [Related]
39. In vitro cell-free conversion of bacterial recombinant PrP to PrPres as a model for conversion.
Kirby L; Birkett CR; Rudyk H; Gilbert IH; Hope J
J Gen Virol; 2003 Apr; 84(Pt 4):1013-1020. PubMed ID: 12655105
[TBL] [Abstract][Full Text] [Related]
40. Establishment of a simple cell-based ELISA for the direct detection of abnormal isoform of prion protein from prion-infected cells without cell lysis and proteinase K treatment.
Shan Z; Yamasaki T; Suzuki A; Hasebe R; Horiuchi M
Prion; 2016 Jul; 10(4):305-18. PubMed ID: 27565564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
